(2R,3R)-5-Amino-3-(4-phenyl-piperidin-1-yl)-1,2,3,4-tetrahydro-naphthalen-2-ol

ID: ALA87381

Chembl Id: CHEMBL87381

Cas Number: 141436-23-9

PubChem CID: 10019050

Max Phase: Preclinical

Molecular Formula: C21H26N2O

Molecular Weight: 322.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1cccc2c1C[C@@H](N1CCC(c3ccccc3)CC1)[C@H](O)C2

Standard InChI:  InChI=1S/C21H26N2O/c22-19-8-4-7-17-13-21(24)20(14-18(17)19)23-11-9-16(10-12-23)15-5-2-1-3-6-15/h1-8,16,20-21,24H,9-14,22H2/t20-,21-/m1/s1

Standard InChI Key:  CELYMPNBUOGKMD-NHCUHLMSSA-N

Associated Targets(non-human)

Vesicular acetylcholine transporter (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc18a3 Vesicular acetylcholine transporter (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (1607 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.45Molecular Weight (Monoisotopic): 322.2045AlogP: 2.98#Rotatable Bonds: 2
Polar Surface Area: 49.49Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.75CX LogP: 3.11CX LogD: 0.79
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.84Np Likeness Score: 0.40

References

1. Efange SM, Khare AB, Foulon C, Akella SK, Parsons SM..  (1994)  Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.,  37  (16): [PMID:8057300] [10.1021/jm00042a010]
2. Barthel C, Sorger D, Deuther-Conrad W, Scheunemann M, Schweiger S, Jäckel P, Roghani A, Steinbach J, Schüürmann G, Sabri O, Brust P, Wenzel B..  (2015)  New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.,  100  [PMID:26071858] [10.1016/j.ejmech.2015.05.033]

Source